Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Carlsmed granted inducement equity awards to newly hired CFO Richard Heppenstall on September 28, 2026: stock options for 180,137 shares plus 89,286 RSUs. On October 1, 2026, the company granted new Chief Product and AI Officer Anthony Jarc options for 132,464 shares plus 63,735 RSUs, both outside the equity plan under Nasdaq Listing Rule 5635(c)(4).
Key figures
- Jarc rsus
- 63735
- Jarc options
- 132464
- Heppenstall rsus
- 89286
- Heppenstall options
- 180137
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.